Mustang Bio, Inc. Share Price
NASDAQ: MBIO | Micro CapMustang Bio, Inc. Stock Performance
Mustang Bio, Inc. Share Price Today
As of 19 September 2026, Mustang Bio, Inc.'s share price is $0.51. The stock opened at $0.50, compared to its previous close of $0.49. During today's trading session, Mustang Bio, Inc.'s share price traded between $0.50 and $0.50, with an average price of $0.50. Over the past 52 weeks, the stock has recorded a high of $1.83 and a low of $0.49. In terms of performance, Mustang Bio, Inc.'s share price has declined by 29.77% over the last six months and is down 66.24% on a year-on-year basis.
Mustang Bio, Inc. Share Price Chart
Mustang Bio, Inc. Quarterly Profit & Loss
All figures in USD
Mustang Bio, Inc. Annual Profit & Loss
All figures in USD
About Mustang Bio, Inc.
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases. It develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-101, an IL13Ra2 CAR T cell program for glioblastoma; and MB-108 for the treatment of herpes simplex virus-1 oncolytic virus C134. The company was incorporated in 2015 and is headquartered in Waltham, Massachusetts.
Mustang Bio, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Sep 2026 | $0.55 | $0.50 | -10.71% |
Aug 2026 | $0.57 | $0.56 | -5.08% |
Jul 2026 | $0.70 | $0.59 | -15.11% |
Jun 2026 | $0.73 | $0.69 | +4.67% |
May 2026 | $0.75 | $0.66 | -10.39% |
Apr 2026 | $0.73 | $0.74 | +1.09% |
Mar 2026 | $0.91 | $0.73 | -28.14% |
Feb 2026 | $0.98 | $1.02 | +2.31% |
Jan 2026 | $1.05 | $1.00 | +1.22% |
Dec 2025 | $1.36 | $0.98 | -30.14% |
Nov 2025 | $1.41 | $1.41 | -3.42% |
Oct 2025 | $1.58 | $1.46 | -4.26% |